MHRA Approves Dovonex Psoriasis Ointment
The UK Medicines and Healthcare products Regulatory Agency has approved Dovonex for psoriasis treatment.
The ointment will be available to adults over 18 without a prescription after a consultation with a pharmacist to diagnosed psoriasis patients. The product can be used up to 12 weeks, after which patients are advised to consult a doctor.
The ointment, containing vitamin D analog calcipotriol, will be provided in 60g tubes.